source
- Medicare withholds cost data for senior GLP-1 obesity drugs as Massachusetts sues UnitedHealthMedicare announced that seniors can obtain Wegovy and Zepbound for $50 a month starting in July, but the agency has not disclosed how much the program will cost taxpayers. The absence of cost tran…
- Agios pays $25 million for global rights to Oscotec’s SYK inhibitor cevidoplenibAgios Therapeutics announced it has secured an exclusive worldwide license for Oscotec’s experimental SYK inhibitor, cevidoplenib. Under the agreement, Agios will pay $25 million up front to Oscot…